AMITRIPTYLINE\PERPHENAZINE: 257 Adverse Event Reports & Safety Profile
Wake Up Pain-Free — Sleep Like Never Before
Derila Ergo Pillow: ergonomic design, cooling tech. 75% OFF today.
257
Total FAERS Reports
7 (2.7%)
Deaths Reported
151
Hospitalizations
257
As Primary/Secondary Suspect
52
Life-Threatening
8
Disabilities
Active Ingredient: AMITRIPTYLINE HYDROCHLORIDE\PERPHENAZINE ·
First Report: 1973 · Latest Report: 20231117
What Are the Most Common AMITRIPTYLINE\PERPHENAZINE Side Effects?
#1 Most Reported
Pain
126 reports (49.0%)
#2 Most Reported
Mobility decreased
120 reports (46.7%)
#3 Most Reported
Balance disorder
99 reports (38.5%)
All AMITRIPTYLINE\PERPHENAZINE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Pain | 126 | 49.0% | 0 | 88 |
| Mobility decreased | 120 | 46.7% | 0 | 94 |
| Balance disorder | 99 | 38.5% | 0 | 93 |
| Fall | 98 | 38.1% | 0 | 94 |
| Cognitive disorder | 97 | 37.7% | 0 | 94 |
| Constipation | 97 | 37.7% | 0 | 94 |
| Blood calcium decreased | 96 | 37.4% | 0 | 93 |
| Creatinine renal clearance decreased | 96 | 37.4% | 0 | 93 |
| Depressed level of consciousness | 96 | 37.4% | 0 | 93 |
| Hypotension | 96 | 37.4% | 0 | 93 |
| Orthostatic hypotension | 96 | 37.4% | 0 | 93 |
| Sedation | 96 | 37.4% | 0 | 93 |
| Toxicity to various agents | 96 | 37.4% | 0 | 92 |
| Sedation complication | 89 | 34.6% | 0 | 89 |
| Off label use | 60 | 23.4% | 0 | 30 |
| Drug interaction | 59 | 23.0% | 0 | 36 |
| Drug ineffective | 49 | 19.1% | 0 | 0 |
| Dyspnoea | 47 | 18.3% | 0 | 35 |
| Drug abuse | 46 | 17.9% | 0 | 45 |
| Product use in unapproved indication | 37 | 14.4% | 0 | 30 |
Who Reports AMITRIPTYLINE\PERPHENAZINE Side Effects? Age & Gender Data
Gender: 96.4% female, 3.6% male. Average age: 72.3 years. Most reports from: CA. View detailed demographics →
Is AMITRIPTYLINE\PERPHENAZINE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2011 | 6 | 0 | 6 |
| 2013 | 2 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 3 | 0 | 1 |
| 2016 | 4 | 0 | 0 |
| 2017 | 3 | 0 | 3 |
| 2018 | 7 | 3 | 3 |
| 2019 | 8 | 0 | 5 |
| 2020 | 9 | 0 | 7 |
| 2021 | 8 | 0 | 8 |
| 2022 | 6 | 0 | 0 |
| 2023 | 2 | 0 | 2 |
What Is AMITRIPTYLINE\PERPHENAZINE Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 80 |
| Insomnia | 77 |
| Constipation | 33 |
| Arthritis | 32 |
| Coronary artery disease | 32 |
| Dementia | 32 |
| Duodenal ulcer | 32 |
| Fibromyalgia | 32 |
| Hypertension | 32 |
| Rheumatoid arthritis | 31 |
AMITRIPTYLINE\PERPHENAZINE vs Alternatives: Which Is Safer?
AMITRIPTYLINE\PERPHENAZINE vs AMIVANTAMAB
AMITRIPTYLINE\PERPHENAZINE vs AMIVANTAMAB-VMJW
AMITRIPTYLINE\PERPHENAZINE vs AMLODIPINE
AMITRIPTYLINE\PERPHENAZINE vs AMLODIPINE BESILATE
AMITRIPTYLINE\PERPHENAZINE vs AMLODIPINE\ATORVASTATIN
AMITRIPTYLINE\PERPHENAZINE vs AMLODIPINE\BENAZEPRIL
AMITRIPTYLINE\PERPHENAZINE vs AMLODIPINE\HYDROCHLOROTHIAZIDE\OLMESARTAN
AMITRIPTYLINE\PERPHENAZINE vs AMLODIPINE\HYDROCHLOROTHIAZIDE\OLMESARTAN MEDOXOMIL
AMITRIPTYLINE\PERPHENAZINE vs AMLODIPINE\HYDROCHLOROTHIAZIDE\VALSARTAN
AMITRIPTYLINE\PERPHENAZINE vs AMLODIPINE\INDAPAMIDE\PERINDOPRIL
Official FDA Label for AMITRIPTYLINE\PERPHENAZINE
Official prescribing information from the FDA-approved drug label.